| Source HCPCS Code |
|
Target NDC Code |
Q5098
Injection, ustekinumab-srlf (imuldosa), biosimilar, 1 mg
|
⇄
|
69448-0017-63
IMULDOSA 45 MG/0.5 ML SYRINGE
|
| Detail Information |
| Relationship Start Date |
01/01/2026 |
| Relationship End Date |
12/31/3999 |
| Number Of Items In Ndc Package |
0.5 |
| Ndc Package Measure |
ML |
| Ndc Package Type |
SYRINGE |
| Route Of Administration |
SQ |
| Billing Units |
ML |
|
|
|
Q5098
Injection, ustekinumab-srlf (imuldosa), biosimilar, 1 mg
|
⇄
|
69448-0018-63
IMULDOSA 90 MG/ML SYRINGE
|
| Detail Information |
| Relationship Start Date |
01/01/2026 |
| Relationship End Date |
12/31/3999 |
| Number Of Items In Ndc Package |
1 |
| Ndc Package Measure |
ML |
| Ndc Package Type |
SYRINGE |
| Route Of Administration |
SQ |
| Billing Units |
ML |
|
|
|
Q5098
Injection, ustekinumab-srlf (imuldosa), biosimilar, 1 mg
|
⇄
|
69448-0019-26
IMULDOSA 130 MG/26 ML VIAL
|
| Detail Information |
| Relationship Start Date |
01/01/2026 |
| Relationship End Date |
12/31/3999 |
| Number Of Items In Ndc Package |
26 |
| Ndc Package Measure |
ML |
| Ndc Package Type |
VIAL |
| Route Of Administration |
IV |
| Billing Units |
ML |
|
|
|